Background: The aim of the study was to validate the association between the Arg166His polymorphisms of the Fc immunoglobulin receptor 2A (FCGR2A) and the Val212Phe of FCGR3A and pathological clinical response (pCR) to trastuzumab in HER2-positive breast cancer patients. Methods: Polymorphisms were characterized by pyrosequencing in 26 patients with ductal histotype breast cancer in a neoadjuvant setting and genotype association with pCR was analyzed. Results: No association was found between the FCGR3A Val212Phe polymorphisms and pCR. In contrast, the FCGR2A GG genotype (Arg allele) was found to be positively associated with pCR (P = 0.012). Conclusions: Our results do not support previously reported data on the effect of polymorphisms in immunoglobulin Fc receptors upon response to trastuzumab therapy.
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value? / Botticelli, Andrea; Mazzuca, Federica; Borro, Marina; Mazzotti, Eva; La Torre, Marco; Bonifacino, Adriana; Ciabatta, Francesca Romana; Gentile, Giovanna; Maddalena, Chiara; Simmaco, Maurizio; Marchetti, Paolo. - In: WORLD JOURNAL OF ONCOLOGY. - ISSN 1920-4531. - 6:5(2015), pp. 437-440. [10.14740/wjon934w]
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?
Botticelli, Andrea;Mazzuca, Federica;Borro, Marina;Mazzotti, Eva;La Torre, Marco;Bonifacino, Adriana;Ciabatta, Francesca Romana;Gentile, Giovanna;Simmaco, Maurizio;
2015
Abstract
Background: The aim of the study was to validate the association between the Arg166His polymorphisms of the Fc immunoglobulin receptor 2A (FCGR2A) and the Val212Phe of FCGR3A and pathological clinical response (pCR) to trastuzumab in HER2-positive breast cancer patients. Methods: Polymorphisms were characterized by pyrosequencing in 26 patients with ductal histotype breast cancer in a neoadjuvant setting and genotype association with pCR was analyzed. Results: No association was found between the FCGR3A Val212Phe polymorphisms and pCR. In contrast, the FCGR2A GG genotype (Arg allele) was found to be positively associated with pCR (P = 0.012). Conclusions: Our results do not support previously reported data on the effect of polymorphisms in immunoglobulin Fc receptors upon response to trastuzumab therapy.| File | Dimensione | Formato | |
|---|---|---|---|
|
trast.pdf
accesso aperto
Note: Botticelli_FCGRs Polymorphisms_2015
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
292.3 kB
Formato
Adobe PDF
|
292.3 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
